XML 50 R37.htm IDEA: XBRL DOCUMENT
v3.4.0.3

Business Acquisition (Narrative) (Details) $ in Thousands | 1 Months Ended | 3 Months Ended |  |
--- | --- | --- | --- | ---
Mar. 31, 2016 USD ($) item | Jan. 31, 2016 USD ($) | Mar. 31, 2016 USD ($) | Dec. 31, 2015 USD ($) | Dec. 31, 2014 USD ($)
Business Acquisition |  |  |  |  |
Payment to Acquire Business, Gross | $ 4,000 |  | $ 4,761 |  |
Number of Injectable Products Acquired | item | 14 |  |  |  |
Number of Different Injectable Chemical Entities | item | 11 |  |  |  |
Goodwill recognized | $ 4,321 |  | 4,321 | $ 3,726 | $ 4,467
Hikma Pharmaceuticals PLC |  |  |  |  |
Business Acquisition |  |  |  |  |
Payment to Acquire Business, Gross | $ 4,000 |  |  |  |
Number of Injectable Products Acquired | item | 14 |  |  |  |
Number of Different Injectable Chemical Entities | item | 11 |  |  |  |
Assets acquired | $ 4,000 |  | $ 4,000 |  |
Letop |  |  |  |  |
Business Acquisition |  |  |  |  |
Payment to Acquire Business, Gross |  | $ 800 |  |  |
Goodwill recognized |  | 500 |  |  |
Assets acquired |  | 1,300 |  |  |
Liabilities assumed |  | $ 1,000 |  |  |

X
- Definition Represents the number of different injectable chemical entities. + References No definition available. + Details
Name: | amph_NumberOfDifferentInjectableChemicalEntities
Namespace Prefix: | amph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of injectables acquired during the period. + References No definition available. + Details
Name: | amph_NumberOfInjectableProductsAcquired
Namespace Prefix: | amph_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of assets acquired at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of liabilities assumed at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=amph_HikmaPharmaceuticalsPlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=amph_NanjingLetopMedicalTechnologyCo.Ltd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |